COVID-19 Impact to the Global Surgical Masks and Respirators Market – New Forecast Released by LSI

Global sales of surgical masks and respirators are projected to reach over $10 billion in 2020. This number represents a massive increase over historical data LSI has been reporting for the last decade.

HUNTINGTON BEACH, Calif.–(BUSINESS WIRE)–#lsintelligenceLife Science Intelligence (LSI) has been tracking and publishing market data on the global surgical apparel market and protective personal equipment (PPE) market for the last decade. LSI’s new market report, Global Opportunities in Surgical Masks and Respirators Market – Impact Analysis of Coronavirus Outbreak provides a reliable and independent forecast of the COVID-19 impact to these markets.

According to the new report, global sales of surgical masks and respirators will exceed pre-pandemic estimates for these products by 211% and 305%, respectively. In 2020, global sales of surgical masks and respirators are projected to reach between $8.0 and $10.7 billion, depending on how the virus spreads. A massive increase in demand for these products, coupled with unit shortages, have caused average sale prices to increase by as much as 4X.

The report features three projected forecasts that take into consideration different scenarios of transmission and containment. These forecasts project revenue and units distributed assuming contained, sustained, and widespread transmission of the virus.

Companies covered in this analysis include: 3M (MMM), Cardinal Health (CAH), Honeywell International (HON), Premier, Prestige Ameritech, Alpha Pro Tech (APT), Makrite Industries, Moldex Metric, Aero Pro, Louis M. Gerson Company, Shanghai Dasheng Health Products, Foss Performance Materials, Hakugen Earth, and Shanghai Gangkai Purifying Products Company, among others.

More about this report and other medical device & diagnostic markets impacted by COVID-19 and the corresponding financial crisis can be found here: https://www.lifesciencemarketresearch.com/market-reports

About Life Science Intelligence (LSI)

LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.

Contacts

Scott Pantel

Life Science Intelligence

714 847 3540 Tel

scott@LS-intel.com

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

4 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

4 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

4 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

7 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

9 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

9 hours ago